Skip to main content
  1. Antibody Drug Conjugates
    • Antibody Drug Conjugates
  2. Antibody Drug Conjugates
    • Antibody Drug Conjugates
    • Antibody Drug Conjugates
    • Bi/Multispecifics
    • Formats & Scaffolds
    • Lead Identification & Optimization
    Spotlight Presentation: Accelerating Therapeutic Antibody Development: Merging AI with High-Throughput Biology
  3. Antibody Drug Conjugates
    • Antibody Drug Conjugates
    What are the key considerations for target selection to enhance ADC efficacy? What should be the pay ...
  4. Bi/Multispecifics
    • Bi/Multispecifics
    • Antibody Drug Conjugates
    • Bi/Multispecifics
    • Formats & Scaffolds
    • Lead Identification & Optimization
    Drinks-Canape Reception
  5. Lead Identification & Optimization
    • Lead Identification & Optimization
    Does antibody pharmacology matter, and why? Is there a “right” scaffold for a specific functional go ...
  6. Formats & Scaffolds
    • Formats & Scaffolds
  7. Lead Identification & Optimization
    • Lead Identification & Optimization
    • Antibody Drug Conjugates
    • Bi/Multispecifics
    • Formats & Scaffolds
    • Lead Identification & Optimization
    Afternoon Refreshments
    • Antibody Drug Conjugates
    • Bi/Multispecifics
    • Formats & Scaffolds
    • Lead Identification & Optimization
    1-2-1 Meetings / Networking Break
    • Antibody Drug Conjugates
    • Bi/Multispecifics
    • Formats & Scaffolds
    • Lead Identification & Optimization
    1-2-1 Meetings / Networking Break
    • Antibody Drug Conjugates
    • Bi/Multispecifics
    • Formats & Scaffolds
    • Lead Identification & Optimization
    Spotlight Presentation
    • Antibody Drug Conjugates
    • Bi/Multispecifics
    • Formats & Scaffolds
    • Lead Identification & Optimization
    Networking Lunch
  8. Bi/Multispecifics
    • Bi/Multispecifics
  9. Formats & Scaffolds
    • Formats & Scaffolds
    Which are the best approaches to overcome lower affinity for target specificity and efficacy
  10. Lead Identification & Optimization
    • Lead Identification & Optimization
    • Antibody Drug Conjugates
    • Bi/Multispecifics
    • Formats & Scaffolds
    • Lead Identification & Optimization
    Morning Refreshments
    • Antibody Drug Conjugates
    • Bi/Multispecifics
    • Formats & Scaffolds
    • Lead Identification & Optimization
    1-2-1 Meetings / Networking Break
    • Antibody Drug Conjugates
    • Bi/Multispecifics
    • Formats & Scaffolds
    • Lead Identification & Optimization
    1-2-1 Meetings / Networking Break
  11. Bi/Multispecifics
    • Bi/Multispecifics
  12. Formats & Scaffolds
    • Formats & Scaffolds
    Is broad-based use of conventional IgG somewhat limited by its fundamental biophysical properties? A ...
  13. Lead Identification & Optimization
    • Lead Identification & Optimization
    What are the key issues faced in the in vitro degradation of antibodies, and which (bio)chemical pat ...
  14. Antibody Drug Conjugates
    • Antibody Drug Conjugates
    • Antibody Drug Conjugates
    • Bi/Multispecifics
    • Formats & Scaffolds
    • Lead Identification & Optimization
    • Antibody Drug Conjugates
    • Bi/Multispecifics
    • Formats & Scaffolds
    • Lead Identification & Optimization
    Registration